HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figure All Versions of this Article: 293/1/L96    most recent 00492.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaggar, A. Articles by Clancy, J. P. Search for Related Content PubMed PubMed Citation Articles by Gaggar, A. Articles by Clancy, J. P.

Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients

Departments of ¹Medicine, ²Pediatrics, and ³Physiology/Biophysics, University of Alabama at Birmingham, Birmingham, Alabama

Submitted 27 December 2006 ; accepted in final form 20 March 2007

Matrix metalloproteases (MMPs) are proteolytic enzymes that regulate extracellular matrix turnover and aid in restoring tissue architecture following injury. There is an emerging role for extracellular matrix destruction in the pathogenesis of chronic neutrophilic lung diseases. In this study, we examined the expression and activity profiles of MMPs in lower airway secretions from cystic fibrosis (CF) patients, patients with acute respiratory failure (ARF), and normal controls. A discrete repertoire of MMP isoforms was found in the CF samples, with robust MMP-9 expression compared with normal controls and ARF. CF samples possessed increased levels of active MMP-9, as well as decreased amounts of tissue inhibitor of metalloprotease-1 (TIMP-1), a natural inhibitor of MMP-9. The CF inpatient samples demonstrated fully active MMP-9 activity compared with CF outpatients, ARF, and normal controls. CF samples also demonstrated increased human neutrophil elastase (HNE) levels compared with ARF and normal controls. To examine potential mechanisms for the protease dysregulation seen in the CF clinical samples, in vitro studies demonstrated that HNE could activate pro-MMP-9 and also degrade TIMP-1; this HNE-based activation, however, was not seen with MMP-8. A strong correlation was seen between HNE and MMP-9 activity in CF inpatient samples. Finally, the dysregulated MMP-9 activity seen in CF inpatient sputum samples could be significantly reduced by the use of MMP-9 inhibitors. Collectively, these findings further emphasize the proposed protease/antiprotease imbalance in chronic neutrophilic lung disease, providing a potential mechanism contributing to this proteolytic dysregulation.

matrix metalloprotease; protease; neutrophil elastase; inflammation

This article has been cited by other articles:

				E. Kolaczkowska, W. Grzybek, N. van Rooijen, H. Piccard, B. Plytycz, B. Arnold, and G. Opdenakker Neutrophil elastase activity compensates for a genetic lack of matrix metalloproteinase-9 (MMP-9) in leukocyte infiltration in a model of experimental peritonitis J. Leukoc. Biol., March 1, 2009; 85(3): 374 - 381. [Abstract] [Full Text] [PDF]

				S. M. Rowe, P. L. Jackson, G. Liu, M. Hardison, A. Livraghi, G. M. Solomon, D. B. McQuaid, B. D. Noerager, A. Gaggar, J. P. Clancy, et al. Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 822 - 831. [Abstract] [Full Text] [PDF]

				A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313. [Abstract] [Full Text] [PDF]

				A. Elizur, C. L. Cannon, and T. W. Ferkol Airway Inflammation in Cystic Fibrosis* Chest, February 1, 2008; 133(2): 489 - 495. [Abstract] [Full Text] [PDF]